Indian-origin man's UK start-up set to combat fake news

Agencies
July 23, 2018

London, Jul 23: An Indian-origin entrepreneur's UK-based start-up that uses a machine-learning algorithm to sift fact from fiction is set to combat fake news around the world, including plans for a project specifically targeted at India.

Lyric Jain, a Cambridge University engineering student originally from Mysore, set up Logically last year and has since developed the West Yorkshire-based start-up into a machine-learning platform to filter real from fiction.

The platform, which is currently going through technology trials with partners and advisors, will have its full public launch in September for the UK and the US, and hit India by October.

The aim is for the service to work as a news aggregator as well as an indicator of factual accuracy.

"The Logically platform gathers the biggest news stories from over 70,000 domains and determines the credibility of the claims across each article. It does this by using a machine learning algorithm that is designed to detect logical fallacy, political bias, and incorrect statistics," the 21-year-old techie explains.

"By illuminating the quality of information across these articles, Logically provides users with a transparent and insightful view that allows them to determine how trustworthy the news they read really is," he said.

With a growing number of cases of fake news being exchanged over the WhatsApp messaging service in India, his start-up is exploring ways for artificial intelligence (AI) to accurately assess the validity of information faster than any human can.

India has over 200 million WhatsApp users and with the system being encrypted, it becomes extremely difficult for law enforcement to intervene and stop fake stories from spreading.

"Because of the highly emotive nature of these stories, people are quick to react. This means the time it takes to disprove compelling fake news stories is often too long to prevent action being taken," Jain said.

"We are still exploring options such as an instant verification chatbot on WhatsApp and will announce our plans by the end of the year," he said.

Logically has a board of advisers made up of alumni from both Massachusetts Institute of Technology (MIT) in the US and Cambridge University in the UK and has raised 1 million pound in funding.

It employs 38 people across the UK, India and the US and is planning to almost double that figure.

Jain believes there is an urgent need for greater education around the issue of fake news and misinformation being spread, largely via online networks.

"The technology we are developing will equip people with the tools they need in order to navigate a complex and confusing information landscape better than before, but governments still need to do a better job educating people on the real dangers of interacting with misinformation," he said.

His platform, which combines AI and human intelligence as well as complex analytics, is planned as a first-of-its-kind "intelligent news feed" that he believes may prove to be the future of journalism.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 24,2020

Kuala Lumpur, Feb 24: Malaysian Prime Minister Mahathir Mohamad has submitted his resignation to the king, two sources with direct knowledge of the matter told Reuters on Monday, amid talks of forming a new coalition to govern the country.

Mahathir, 94, assumed office in May 2018 for his second stint as prime minister.

A spokesman from the prime minister's office declined to comment, saying only that a statement will be issued soon.

The sources declined to be named as they were not authorised to talk to the media.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 13,2020

Feb 13: Two Indian crew on board a cruise ship off the Japanese coast have tested positive for the novel coronavirus, the Indian Embassy in Japan said on Wednesday as authorities confirmed that 174 people have been infected with the deadly disease.

The cruise ship Diamond Princess with 3,711 people on board arrived at the Japanese coast early last week and was quarantined after a passenger who de-boarded last month in Hong Kong was found to be the carrier of the novel virus on the ship.

A total of 138 Indians, including passengers and crew, were on board the ship.

“Due to the suspicion of novel coronavirus (nCoV) infection, the ship has been quarantined by the Japanese authorities till February 19, 2020,” the embassy said in a statement.

“Altogether 174 people have been tested positive for nCoV, including two Indian crew members,” it said.

All the infected people have been taken to hospitals for adequate treatment, including further quarantine, in accordance with the Japanese health protocol, it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.